Davis J. E., an insider at Quest Diagnostics Inc (DGX), executed a significant sale of 166,231 shares on November 24, 2025, at a price of $191.59 per share, resulting in a total transaction value of $31.85 million. Following this transaction, J. E. retains an equal number of shares in the company.
Quest Diagnostics, headquartered in Secaucus, New Jersey, operates in the health care sector and employs approximately 45,000 full-time staff. The company provides diagnostic testing and information services, enabling better health outcomes through a nationwide network of laboratories and patient service centers. As of November 25, 2025, Quest Diagnostics boasts a market capitalization of $21.3 billion, a price-to-earnings ratio of 22.00, and an earnings per share figure of 8.52. The company is also known for its focus on artificial intelligence and digital pathology solutions.
Insider selling can arise from various motivations, including diversification or personal financial needs. While notable sales may attract investor scrutiny, they do not inherently signal negative sentiments towards the company. Such transactions, reported to the SEC, provide transparency regarding how executives and board members perceive their stock holdings. Investors are encouraged to consider broader patterns of insider activity across multiple individuals and timeframes to form a more comprehensive view.
Upcoming earnings reports include estimates of $2.39 EPS on April 20, 2026, and $2.78 EPS on July 20, 2026, indicating ongoing interest in the company’s financial performance.